Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme Levels and Histopathology- an Epidemiological Study in Shiraz, Southern Iran, 2003-2004
Seyed Alireza Taghavi
1
, *
,
Shabnam Sedighi
2
,
Davood Mehrabani
2
and
Farnaz Khademolhoesseini
2
1 Gastroenterohepatology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, grc@sums.ac.ir, Fars, IR.Iran
2 Gastroenterohepatology Research Center, Department of Internal Medicine, Shiraz University of Medical Sciences, Fars, IR.Iran
*
Gastroenterohepatology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, grc@sums.ac.ir, Fars, IR.Iran. Tel: +98 711 6276212. Fax: +98 711 6276212. Email:
grc@sums.ac.ir
Hepatitis Monthly: ,
8 (4) ; 248-251 Article Type: Research Article
Received:
January 29, 2008
Accepted:
August 12, 2008
To Cite:
Taghavi
S, Sedighi
S, Mehrabani
D, Khademolhoesseini
F. Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme Levels and Histopathology- an Epidemiological Study in Shiraz, Southern Iran, 2003-2004,
Hepat Mon.
Online ahead of Print
;8(4):248-251.
Abstract
Background and Aims: At least 5% of hepatitis B carriers worldwide are infected with Hepatitis D virus ( HDV). This study aims to determine the prevalence, transaminase levels and histopathological findings of HDV among patients with chronic active hepatitis B in southern Iran.
Methods: During 2003-2004, 93 patients > 15 years with chronic active hepatitis B were enrolled from referrals to Shiraz University of Medical Sciences in southern Iran.
Results: Nine (9.7%) patients were seropositive for the anti HDV antibody. 76.3% of patients were male and among the HDV positive group, all subjects were male too. A significantly higher AST and more advanced grade and stage of liver disease were observed in the HDV positive group. The most common mode of transmission in the positive group was intravenous drug use.
Conclusions: The risk of liver disease progression in chronic hepatitis B appears to be higher in HDV infected patients. Intravenous drug abuse is an important risk factor for acquiring HDV infection. Checking anti-HDV is suggested in any patient with positive HBsAg, especially in males or those with history of intravenous drug abuse.
© 0, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Except where otherwise noted, this work is licensed under
Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments